tiprankstipranks
Trending News
More News >
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market

Marksans Pharma Limited (MARKSANS) Financial Statements

Compare
2 Followers

Marksans Pharma Limited Financial Overview

Marksans Pharma Limited's market cap is currently ₹118.19B. The company's EPS TTM is ₹2.1; its P/E ratio is 31.05; and it has a dividend yield of 0.23%. Marksans Pharma Limited is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 21.77B₹ 18.52B₹ 14.80B₹ 13.68B₹ 11.29B
Gross Profit₹ 10.83B₹ 9.31B₹ 7.32B₹ 7.50B₹ 5.61B
Operating Income₹ 7.79B₹ 2.88B₹ 2.14B₹ 3.09B₹ 1.70B
EBITDA₹ 5.09B₹ 3.99B₹ 3.01B₹ 3.46B₹ 1.93B
Net Income₹ 3.14B₹ 2.66B₹ 1.85B₹ 2.39B₹ 1.21B
Balance Sheet
Cash & Short-Term Investments₹ 7.00B₹ 7.19B₹ 3.47B₹ 2.09B₹ 931.21M
Total Assets₹ 26.81B₹ 21.90B₹ 16.40B₹ 12.28B₹ 8.97B
Total Debt₹ 2.44B₹ 1.23B₹ 1.11B₹ 341.02M₹ 296.50M
Net Debt₹ -1.59B₹ -2.59B₹ -2.35B₹ -1.75B₹ -634.71M
Total Liabilities₹ 5.95B₹ 4.25B₹ 4.17B₹ 3.23B₹ 2.48B
Stockholders' Equity₹ 20.65B₹ 17.45B₹ 12.02B₹ 8.86B₹ 6.36B
Cash Flow
Free Cash Flow₹ 215.69M₹ 1.84B₹ 529.27M₹ 1.32B₹ 1.50B
Operating Cash Flow₹ 2.30B₹ 2.37B₹ 992.57M₹ 1.79B₹ 2.10B
Investing Cash Flow₹ -1.41B₹ -2.59B₹ -416.86M₹ -448.96M₹ -595.30M
Financing Cash Flow₹ -687.27M₹ 1.98B₹ 795.11M₹ -152.86M₹ -901.48M
Currency in INR

Marksans Pharma Limited Earnings and Revenue History

Marksans Pharma Limited Debt to Assets

Marksans Pharma Limited Cash Flow

Marksans Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis